查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2132843

基因編輯種子市場規模、佔有率、趨勢和預測分析：編輯技術、特性、作物類型、監管分類、最終用戶和地區——全球預測至2036年

Gene-Edited Seeds Market Size, Share, Trends & Forecast Analysis by Editing Technology, Trait, Crop Type, Regulatory Category, End User, and Geography - Global Forecast to 2036
出版日期: | 出版商: Meticulous Research | 英文 326 Pages | 訂單完成後即時交付

價格

全球基因編輯種子市場預計在2026年達到39.3億美元，並預計到2036年將達到237億美元。預測期內，該市場預計將以19.7%的複合年成長率成長。本報告對快速發展的基因編輯種子市場進行了全面評估，分析了市場趨勢、技術進步、競爭格局以及精準育種和農業生物技術領域的未來成長機會。

利用CRISPR-Cas9、CRISPR-Cas12a (Cpf1)、鹼基編輯、先導編輯、寡核苷酸誘變和TALENs等精準基因組編輯技術開發的基因編輯種子，能夠對植物自身基因組進行特異性改造，正逐漸成為加速作物和特種作物性狀改良的有效解決方案。與傳統的基因改造方法不同，許多基因編輯技術無需引入外源遺傳物質即可修改植物現有的DNA。這一差異使得基因編輯種子在越來越多的地區獲得了差異化且日益有利的監管待遇。全球日益完善的監管環境、相比傳統育種和基因改造技術而言快速且經濟高效的性狀改良，以及對耐候性和投入效率高的作物品種日益成長的需求，共同推動了基因編輯種子在世界範圍內大田作物、糧食作物和特種作物領域的廣泛應用。

本報告透過分析技術創新、應用趨勢、監管動態、授權和合作活動、投資活動以及影響行業成長的競爭策略，對市場進行了詳細評估。該報告還評估了多重編輯、微調、人工智慧驅動的性狀設計和平台許可模式的進步如何提升性狀性能、縮短開發週期並增強生產者信心。此外，本研究還提供策略性市場預測、細分市場洞察和區域分析，以支援企業、投資和農業技術決策。

市場動態

在全球範圍內，圍繞基因編輯作物的法規環境日益有利且不斷擴展，這仍然是基因編輯種子市場的主要驅動力之一。隨著主要農業經濟體的法規結構日益明確地區分特定的基因編輯植物和傳統的基因改造生物，種子研發者能夠以更短的時間和更少的數據生成負擔將新的性狀推向市場。歐盟的《新型基因組技術條例》（於2026年7月生效，並將於2028年7月開始實施）、英國的《精準育種框架》（自2025年11月起生效）、印度對SDN-1和SDN-2基因編輯的豁免以及中國的基因編輯指導方針，都表明國家和同地區比例的監管機構正朝著國家和同地區比例的監管機構正朝著國家和地區提供基於比例的監管產品。生產者對精準育種技術的認知不斷提高，基因編輯作為傳統育種的補充越來越被接受，以及人們越來越傾向於選擇氣候適應性強、投入效率高的品種而不是繼續依賴傳統作物遺傳學，這些因素進一步加速了基因編輯技術的普及應用。

持續的技術創新正在重塑競爭格局。開發者們正在推出新一代基因編輯平台，這些平台具有多層精細調控的性狀編輯、人工智慧驅動的預測性狀設計、能夠實現更大規模、更精確基因組改變的基礎和先導編輯、不含新型核酸酶和基因改造的遞送系統，以及將技術開發者與成熟的種子和食品行業合作夥伴連接起來的增強型許可模式。編輯精度、性狀堆疊和平台許可方面的創新正在縮短開發週期，並擴大具有商業性價值的性狀範圍。此外，領先的種子和作物科學公司加大對基因編輯平台的策略性投資和重組，預計將進一步最佳化性狀研發管線和跨區域商業化。

儘管市場環境有利，但仍有許多挑戰影響著產業的普及。關鍵市場法律規範不明確且分散，不同司法管轄區的進度安排和數據要求各異，以及智慧財產權糾紛和專利複雜性，仍是影響市場擴張的重要因素。雖然對基礎編輯專利、改良酶和導入方法、編輯基因和性狀以及遺傳資源的權利是自由開展業務的必要條件，但持續不斷的訴訟和專利衝突程序仍然給小規模育種者帶來不確定性。此外，關鍵市場的監管變化和區域註冊要求的差異可能會限制某些地區的更廣泛應用。

儘管如此，該市場仍蘊藏著巨大的長期機會。透過授權性狀平台拓展到特種作物和園藝作物領域，透過國家基因組編輯框架加強對新興市場商業化的投資，加強多元化種子企業與專業基因編輯研發公司之間的合作，以及基因編輯精準度技術的持續進步，預計都將為未來的市場成長創造有利條件。隨著農業系統不斷優先考慮應對氣候變遷的能力、投入效率和長期糧食安全，預計已開發農業市場和新興農業市場對基因編輯種子的需求都將顯著成長。

細分市場分析

本報告透過編輯技術、特性、作物類型、監管分類、最終用戶和地區，提供詳細的市場分析，幫助相關人員了解精準育種的成長機會和不斷變化的趨勢。

目錄

  • 目錄

第1章：引言

第2章：調查方法

第3章執行摘要

第4章 市場洞察

  • 影響市場成長的因素
    • 促進因素
      • 全球法規環境日益有利且不斷擴大。
      • 與基因改造育種相比，它可以更快、更低成本地開發性狀。
      • 對能夠抵抗氣候變遷且投入效率高的作物品種的需求日益成長。
    • 抑制因子
      • 主要市場的法律規範不確定性和碎片化
    • 機會
      • 透過授權性狀平台，將業務拓展至特種作物和園藝作物領域。
      • 透過國家基因組編輯框架在新興市場實現商業化
    • 任務
      • 智慧財產權糾紛和專利的複雜性預計在未來仍將是重大挑戰。
  • 主要趨勢
    • 圍繞基因編輯平台和授權的企業重組
    • 過渡到連接複用和精細化的照片編輯
  • 供應商選擇標準/影響採購決策的因素
  • 用例
  • 波特五力分析
  • 價值鏈分析
  • 價格分析（性狀許可費與傳統種子溢價）
  • 編輯平台和知識產權現狀分析
  • 特徵開發平臺分析
  • 監管情勢（美國動植物衛生檢驗局架構、歐盟關於新基因組技術的法規、英國精準育種法規、印度SDN-1、中國MARA基因編輯指南）
  • 政府支持和公私合作研究的趨勢
  • PESTLE分析

第5章：基因編輯種子市場評估：基於編輯技術

  • 基於 CRISPR-Cas9
  • 基於 CRISPR-Cas12a (Cpf1)
  • 低音編輯
  • 主編
  • 寡核苷酸誘導的誘變
  • 基於TALEN方法

第6章：基因編輯種子市場評估：依性狀分類

  • 除草劑抗性
  • 抗病蟲害能力
  • 提高產量、成分和品質
  • 非生物脅迫耐受性
  • 其他特徵

第7章 基因改造種子市場評估：依作物類型分類

  • 玉米
  • 大豆
  • 小麥
  • 米
  • 菜籽和菜籽
  • 棉布
  • 水果、蔬菜和特色作物
  • 其他作物

第8章 基因改造種子市場評估：依監管類別分類

  • SDN-1
  • SDN-2
  • SDN-3/Sysgenic

第9章：基因編輯種子市場評估：依最終用戶分類

  • 田間作物
  • 特種作物生產商
  • 種子企業（性狀許可）
  • 食品/飼料/食品原料加工商

第10章：基因編輯種子市場評估：按地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 北歐國家
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲和紐西蘭
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲國家

第11章 競爭格局

  • 關鍵成長策略
  • 競爭性基準測試（裁切面積、編輯平台、性狀流程、註冊區域）
  • 競爭對手儀錶板
    • 產業領導者
    • 市場差異化因素
    • 先鋒公司
    • 新興企業
  • 市場佔有率和定位分析

第12章：公司簡介

  • Corteva, Inc.
  • Bayer AG
  • BASF SE
  • Syngenta Group
  • KWS SAAT SE & Co. KGaA
  • Groupe Limagrain
  • JR Simplot Company
  • Cibus, Inc.
  • Pairwise
  • Inari Agriculture, Inc.
  • Tropic Biosciences UK Limited
  • KeyGene NV
  • Evogene Ltd.
  • Beijing Dabeinong Technology Group Co., Ltd.
  • Qi Biodesign
  • Origin Agritech Limited

第13章附錄

Product Code: MRAGR - 1042167

The global Gene-Edited Seeds Market is estimated to be valued at USD 3.93 billion in 2026 and is projected to reach USD 23.70 billion by 2036, expanding at a CAGR of 19.7% during the forecast period. The report provides a comprehensive evaluation of the rapidly evolving gene-edited seeds market by examining market trends, technological advancements, competitive developments, and future growth opportunities across the precision breeding and agricultural biotechnology landscape.

Gene-edited seeds have emerged as an effective solution for accelerating trait development in row crop and specialty crop agriculture, developed using precision genome-editing technologies such as CRISPR-Cas9, CRISPR-Cas12a (Cpf1), base editing, prime editing, oligonucleotide-directed mutagenesis, and TALENs to make targeted changes to a plant's own genome. Unlike conventional transgenic approaches, many gene-editing applications modify a plant's existing DNA without introducing foreign genetic material, a distinction that has contributed to differentiated and increasingly favorable regulatory treatment across a growing number of jurisdictions. The increasingly supportive global regulatory landscape, faster and lower-cost trait development relative to conventional and transgenic breeding, and rising demand for climate-resilient, input-efficient crop varieties are driving widespread adoption of gene-edited seeds across row-crop, cereal, and specialty agriculture worldwide.

This report delivers an in-depth assessment of the market by analyzing technological innovations, adoption trends, regulatory developments, licensing and partnership activity, investment activities, and competitive strategies shaping industry growth. It evaluates how advancements in multiplexed and fine-tuned editing, AI-assisted trait design, and platform licensing models are improving trait performance, development timelines, and grower confidence. The study also provides strategic market forecasts, segment-level insights, and regional analysis to support informed business, investment, and agricultural technology decisions.

Market Dynamics

The increasingly favorable and expanding global regulatory treatment of gene-edited crops remains one of the primary drivers of the gene-edited seeds market. As regulatory frameworks in major agricultural economies increasingly differentiate certain gene-edited plants from conventional transgenic GMOs, seed developers are increasingly able to bring new traits to market with shorter timelines and lower data-generation burdens. The European Union's New Genomic Techniques Regulation, which entered into force in July 2026 and applies from July 2028, England's precision breeding framework in force since November 2025, India's exemption of SDN-1 and SDN-2 edits, and China's gene-editing guidelines illustrate how national and regional frameworks are converging toward proportionate, product-based oversight. Growing grower awareness of precision breeding technology, increasing acceptance of gene editing as a complement to conventional breeding, and increasing grower preference for climate-resilient, input-efficient varieties over continued reliance on conventional crop genetics are further accelerating adoption.

Continuous technological innovation is reshaping the competitive landscape. Developers are introducing next-generation gene-editing platforms featuring multiplexed and fine-tuned trait editing, AI-assisted predictive trait design, base and prime editing capable of larger and more precise genomic changes, novel nucleases and transgene-free delivery systems, and expanded licensing models that connect technology developers with established seed and food-industry partners. Innovations in editing precision, trait stacking, and platform licensing are improving development timelines while broadening the range of commercially viable traits. Furthermore, increasing strategic investment and corporate realignment by major seed and crop science companies around gene-editing platforms is expected to further optimize trait pipelines and multi-geography commercialization.

Despite favorable market conditions, several challenges continue to influence industry adoption. Unsettled and fragmented regulatory oversight across key markets, differing timelines and data requirements between jurisdictions, and intellectual property disputes and patent complexity remain important considerations affecting market expansion. Freedom to operate requires rights across foundational editing patents, improved enzymes and delivery methods, edited genes and traits, and germplasm, and ongoing litigation and interference proceedings continue to create uncertainty for smaller breeders. In addition, regulatory transitions in major markets and registration variability across geographies may limit broader adoption in certain regions.

The market nevertheless presents substantial long-term opportunities. Expansion into specialty and horticultural crops through licensed trait platforms, increasing investment in emerging-market commercialization through national genome-editing frameworks, growing collaboration between diversified seed companies and specialized gene-editing developers, and continuous technological advancement in editing precision are expected to create favorable conditions for future market growth. As agricultural systems continue to emphasize climate resilience, input efficiency, and long-term food security, demand for gene-edited seeds is expected to increase significantly across both developed and emerging agricultural markets.

Segment Analysis

The report provides detailed market analysis across editing technology, trait, crop type, regulatory category, end user, and geography, enabling stakeholders to identify high-growth business opportunities and evolving precision breeding trends.

Based on editing technology, the market is segmented into CRISPR-Cas9-based, CRISPR-Cas12a (Cpf1)-based, base editing, prime editing, oligonucleotide-directed mutagenesis, and TALEN-based editing. In 2026, the CRISPR-Cas9-based segment is expected to account for the largest share of the global gene-edited seeds market. The large share of this segment is attributed to the maturity and efficiency of CRISPR-Cas9 across major crops, the availability of foundational licenses, and its use in several of the first approved gene-edited products. However, the prime editing segment is slated to register the highest growth during the forecast period, as prime editors enable substitutions, insertions, and deletions without a donor template and move from research into commercial trait development.

From a trait perspective, the report evaluates herbicide tolerance, disease & pest resistance, yield & compositional/quality improvement, abiotic stress tolerance, and other traits. The yield & compositional/quality improvement segment is expected to account for the largest share of the market in 2026, reflecting the concentration of commercial gene-edited products in quality and yield traits such as waxy corn, high-oleic soybean, higher-yielding rice, and non-browning bananas. The abiotic stress tolerance segment is projected to record the highest growth during the forecast period, as drought, heat, and salinity tolerance programs gain priority across Asia-Pacific, Latin America, and the Middle East & Africa.

The report also analyzes market performance across corn, soybean, wheat, rice, canola & oilseed rape, cotton, fruits, vegetables & specialty crops, and other crop types, as well as across SDN-1, SDN-2, and SDN-3/cisgenic regulatory categories. Corn accounts for the largest share of the market, given the scale of commercialized and pipeline traits in the crop, while rice is expected to witness the fastest growth, as gene-edited rice varieties gain regulatory approval and commercial release across major producing economies. SDN-1 edits represent the largest regulatory category, owing to their exemption from GMO-level review in several major jurisdictions, while SDN-2 edits are expected to grow fastest rate as developers increasingly use template-directed editing for more specific trait outcomes.

Based on end user, the market is segmented into row crop & field crop growers, specialty crop growers, seed companies (trait licensing), and food, feed & ingredient processors. Row crop & field crop growers are expected to account for the largest share of the market, supported by the concentration of gene-edited products and pipelines in corn, soybean, wheat, rice, and canola. The seed companies (trait licensing) segment is projected to register the highest growth during the forecast period, as technology developers increasingly supply traits and editing platforms to seed companies rather than selling seed directly.

Regional Analysis

The report provides comprehensive market analysis across North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Regional evaluations consider regulatory frameworks, trait development infrastructure, licensing and partnership activity, national genome-editing policy, and investments influencing market growth.

North America is expected to account for the largest share of the global gene-edited seeds market in 2026. his position is supported by the concentration of gene-editing developers and seed companies in the United States, the commercialization of the first gene-edited field crop and food products in the country, the scale of its hybrid corn and soybean seed markets, and Canadian guidance under which most gene-edited plants without foreign DNA do not require pre-market review, tempered by ongoing regulatory transition in the region's biotechnology oversight framework. Europe is entering a new phase of commercial relevance following the adoption of a regulatory framework that differentiates certain gene-edited plants from full genetically modified organism oversight, with the United Kingdom moving fastest through its own dedicated precision-breeding authorization pathway.

Asia-Pacific is expected to register the fastest growth throughout the forecast period, driven by national exemption frameworks and commercial gene-edited crop releases across major economies such as India and China, together with the adoption of gene-editing frameworks in Japan, Australia, and Southeast Asia. Latin America is emerging as a commercialization destination for gene-edited traits developed elsewhere, supported by established consultation procedures in Brazil and Argentina, while the Middle East & Africa region remains an earlier-stage market, with activity concentrated in donor-funded crop development programs.

Competitive Landscape

The report presents a comprehensive evaluation of the competitive environment by examining the strategic positioning of leading market participants, their product portfolios, editing technologies, innovation strategies, partnerships, licensing agreements, geographic regulatory expansion, research and development investments, and recent business developments.

Competitive benchmarking enables stakeholders to evaluate companies based on crop coverage, editing platform performance, trait pipeline breadth, regulatory registration coverage across crops and geographies, licensing and partnership strategy, and global market presence. The study also analyzes how diversified agricultural companies and specialized gene-editing technology developers are leveraging multiplexed editing platforms, AI-assisted trait design, and trait-licensing partnerships to strengthen their competitive positioning within the precision breeding and agricultural biotechnology market. Between 2025 and 2026, partnerships, licensing agreements, and collaborations represented the most frequently adopted growth strategy among leading participants.

Key companies profiled in the report include Corteva, Inc. (U.S.), Bayer AG (Germany), BASF SE (Germany), Syngenta Group (Switzerland), KWS SAAT SE & Co. KGaA (Germany), Groupe Limagrain (France), J.R. Simplot Company (U.S.), Cibus, Inc. (U.S.), Pairwise (U.S.), Inari Agriculture, Inc. (U.S.), Tropic Biosciences UK Limited (U.K.), KeyGene N.V. (Netherlands), Evogene Ltd. (Israel), Beijing Dabeinong Technology Group Co., Ltd. (China), Qi Biodesign (China), and Origin Agritech Limited (China).

How This Report Helps

  • Provides accurate market size estimates and long-term forecasts for the global gene-edited seeds market.
  • Evaluates the impact of editing technologies, trait development, and regulatory frameworks on market growth.
  • Identifies high-growth opportunities across editing technology, trait, crop type, regulatory category, end user, and geographic segments.
  • Analyzes emerging technology trends, regulatory developments, licensing strategies, and innovation strategies shaping market growth.
  • Benchmarks leading companies based on product portfolios, technological capabilities, and competitive positioning.
  • Supports product development, investment planning, partnership evaluation, market entry, and business expansion strategies.
  • Delivers actionable market intelligence for seed and agricultural biotechnology companies, technology developers, growers, investors, and agribusiness organizations.

Key Questions Answered

  • What is the current size of the global gene-edited seeds market, and how is it expected to evolve through 2036?
  • Which technological, regulatory, and economic factors are driving market growth?
  • What are the major drivers, restraints, opportunities, and challenges influencing industry development?
  • Which editing technology, trait, crop type, regulatory category, end-user, and regional segments are expected to experience the strongest growth?
  • How are national and regional genome-editing frameworks shaping trait approvals and commercialization timelines?
  • Which geographic markets present the most attractive business opportunities?
  • Who are the leading companies operating in the market, and what competitive strategies are they adopting?
  • What recent product launches, partnerships, licensing agreements, regulatory approvals, and technological innovations are shaping the competitive landscape?
  • How is the intellectual property landscape influencing freedom to operate and platform licensing strategies?
  • How can stakeholders leverage market intelligence from this report to support investment decisions, product development, competitive benchmarking, and long-term business strategy?

TABLE OF CONTENTS

  • Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Currency & Limitations

2. Research Methodology

  • 2.1. Research Approach
  • 2.2. Data Collection & Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Assessment
    • 2.3.1. Market Size Estimation
    • 2.3.2. Bottom-Up Approach
    • 2.3.3. Top-Down Approach
    • 2.3.4. Growth Forecast
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Drivers
      • 4.2.1.1. Increasingly Favorable and Expanding Global Regulatory Treatment
      • 4.2.1.2. Faster and Lower-Cost Trait Development Relative to Transgenic Breeding
      • 4.2.1.3. Rising Demand for Climate-Resilient and Input-Efficient Crop Varieties
    • 4.2.2. Restraints
      • 4.2.2.1. Unsettled and Fragmented Regulatory Oversight in Key Markets
    • 4.2.3. Opportunities
      • 4.2.3.1. Expansion into Specialty and Horticultural Crops Through Licensed Trait Platforms
      • 4.2.3.2. Emerging-Market Commercialization Through National Genome-Editing Frameworks
    • 4.2.4. Challenges
      • 4.2.4.1. Intellectual Property Disputes and Patent Complexity Expected to Remain a Major Challenge
  • 4.3. Key Trends
    • 4.3.1. Corporate Realignment Around Gene-Editing Platforms and Licensing
    • 4.3.2. Shift Toward Multiplexed and Fine-Tuned Trait Editing
  • 4.4. Vendor Selection Criteria/Factors Influencing Purchase Decisions
  • 4.5. Use Cases
  • 4.6. Porter's Five Forces Analysis
    • 4.6.1. Bargaining Power of Buyers: Moderate
    • 4.6.2. Bargaining Power of Suppliers: Moderate to High
    • 4.6.3. Threat of Substitutes: Moderate
    • 4.6.4. Threat of New Entrants: Moderate
    • 4.6.5. Degree of Competition: High
  • 4.7. Value Chain Analysis
  • 4.8. Pricing Analysis (Trait Licensing Royalty Vs. Conventional Seed Premium)
  • 4.9. Editing Platform and Intellectual Property Landscape Analysis
  • 4.10. Trait Development Pipeline Analysis
  • 4.11. Regulatory Landscape (U.S. APHIS Framework, EU New Genomic Techniques Regulation, U.K. Precision Breeding Regulations, India SDN-1/SDN-2 Exemption, China MARA Gene-Editing Guidelines)
  • 4.12. Government Support and Public-Private Research Landscape
  • 4.13. PESTEL Analysis

5. Gene-Edited Seeds Market Assessment-By Editing Technology

  • 5.1. Overview
  • 5.2. CRISPR-Cas9-Based
  • 5.3. CRISPR-Cas12a (Cpf1)-Based
  • 5.4. Base Editing
  • 5.5. Prime Editing
  • 5.6. Oligonucleotide-Directed Mutagenesis
  • 5.7. TALEN-Based

6. Gene-Edited Seeds Market Assessment-By Trait

  • 6.1. Overview
  • 6.2. Herbicide Tolerance
  • 6.3. Disease & Pest Resistance
  • 6.4. Yield & Compositional/Quality Improvement
  • 6.5. Abiotic Stress Tolerance
  • 6.6. Other Traits

7. Gene-Edited Seeds Market Assessment-By Crop Type

  • 7.1. Overview
  • 7.2. Corn
  • 7.3. Soybean
  • 7.4. Wheat
  • 7.5. Rice
  • 7.6. Canola & Oilseed Rape
  • 7.7. Cotton
  • 7.8. Fruits, Vegetables & Specialty Crops
  • 7.9. Other Crops

8. Gene-Edited Seeds Market Assessment-By Regulatory Category

  • 8.1. Overview
  • 8.2. SDN-1
  • 8.3. SDN-2
  • 8.4. SDN-3/Cisgenic

9. Gene-Edited Seeds Market Assessment-By End User

  • 9.1. Overview
  • 9.2. Row Crop & Field Crop Growers
  • 9.3. Specialty Crop Growers
  • 9.4. Seed Companies (Trait Licensing)
  • 9.5. Food, Feed & Ingredient Processors

10. Gene-Edited Seeds Market Assessment-By Geography

  • 10.1. Overview
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. U.K.
    • 10.3.3. France
    • 10.3.4. Spain
    • 10.3.5. Italy
    • 10.3.6. Netherlands
    • 10.3.7. Nordic Countries
    • 10.3.8. Rest of Europe
  • 10.4. Asia-Pacific
    • 10.4.1. China
    • 10.4.2. India
    • 10.4.3. Japan
    • 10.4.4. South Korea
    • 10.4.5. Australia & New Zealand
    • 10.4.6. Rest of Asia-Pacific
  • 10.5. Latin America
    • 10.5.1. Brazil
    • 10.5.2. Argentina
    • 10.5.3. Mexico
    • 10.5.4. Rest of Latin America
  • 10.6. Middle East & Africa
    • 10.6.1. Saudi Arabia
    • 10.6.2. United Arab Emirates
    • 10.6.3. South Africa
    • 10.6.4. Rest of Middle East & Africa

11. Competitive Landscape

  • 11.1. Introduction
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Benchmarking (Crop Coverage, Editing Platform, Trait Pipeline, Registered Geographies)
  • 11.4. Competitive Dashboard
    • 11.4.1. Industry Leaders
    • 11.4.2. Market Differentiators
    • 11.4.3. Vanguards
    • 11.4.4. Emerging Companies
  • 11.5. Market Share/Position Analysis

12. Company Profiles

  • 12.1. Corteva, Inc.
    • 12.1.1. Business Overview
    • 12.1.2. Financial Overview
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Developments
    • 12.1.5. SWOT Analysis
  • 12.2. Bayer AG
    • 12.2.1. Business Overview
    • 12.2.2. Financial Overview
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Developments
    • 12.2.5. SWOT Analysis
  • 12.3. BASF SE
    • 12.3.1. Business Overview
    • 12.3.2. Financial Overview
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Developments
    • 12.3.5. SWOT Analysis
  • 12.4. Syngenta Group
    • 12.4.1. Business Overview
    • 12.4.2. Financial Overview
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Developments
    • 12.4.5. SWOT Analysis
  • 12.5. KWS SAAT SE & Co. KGaA
    • 12.5.1. Business Overview
    • 12.5.2. Financial Overview
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Developments
    • 12.5.5. SWOT Analysis
  • 12.6. Groupe Limagrain
    • 12.6.1. Business Overview
    • 12.6.2. Financial Overview
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Developments
    • 12.6.5. SWOT Analysis
  • 12.7. J.R. Simplot Company
    • 12.7.1. Business Overview
    • 12.7.2. Financial Overview
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Developments
    • 12.7.5. SWOT Analysis
  • 12.8. Cibus, Inc.
    • 12.8.1. Business Overview
    • 12.8.2. Financial Overview
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Developments
    • 12.8.5. SWOT Analysis
  • 12.9. Pairwise
    • 12.9.1. Business Overview
    • 12.9.2. Financial Overview
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Developments
    • 12.9.5. SWOT Analysis
  • 12.10. Inari Agriculture, Inc.
    • 12.10.1. Business Overview
    • 12.10.2. Financial Overview
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Developments
    • 12.10.5. SWOT Analysis
  • 12.11. Tropic Biosciences UK Limited
    • 12.11.1. Business Overview
    • 12.11.2. Financial Overview
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Developments
    • 12.11.5. SWOT Analysis
  • 12.12. KeyGene N.V.
    • 12.12.1. Business Overview
    • 12.12.2. Financial Overview
    • 12.12.3. Product Portfolio
    • 12.12.4. Strategic Developments
    • 12.12.5. SWOT Analysis
  • 12.13. Evogene Ltd.
    • 12.13.1. Business Overview
    • 12.13.2. Financial Overview
    • 12.13.3. Product Portfolio
    • 12.13.4. Strategic Developments
    • 12.13.5. SWOT Analysis
  • 12.14. Beijing Dabeinong Technology Group Co., Ltd.
    • 12.14.1. Business Overview
    • 12.14.2. Financial Overview
    • 12.14.3. Product Portfolio
    • 12.14.4. Strategic Developments
    • 12.14.5. SWOT Analysis
  • 12.15. Qi Biodesign
    • 12.15.1. Business Overview
    • 12.15.2. Financial Overview
    • 12.15.3. Product Portfolio
    • 12.15.4. Strategic Developments
    • 12.15.5. SWOT Analysis
  • 12.16. Origin Agritech Limited
    • 12.16.1. Business Overview
    • 12.16.2. Financial Overview
    • 12.16.3. Product Portfolio
    • 12.16.4. Strategic Developments
    • 12.16.5. SWOT Analysis

13. Appendix

  • 13.1. Available Customization
  • 13.2. Related Reports

LIST OF TABLES

List of Tables

  • Table 1. Currency Conversion Rates Used in This Study
  • Table 2. Indicative Revenue Structure for Gene-Edited Traits and Seed
  • Table 3. Global Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 4. Global Gene-Edited Seeds Market for CRISPR-Cas9-Based Editing, By Country/Region, 2024-2036 (USD Million)
  • Table 5. Global Gene-Edited Seeds Market for CRISPR-Cas12a (Cpf1)-Based Editing, By Country/Region, 2024-2036 (USD Million)
  • Table 6. Global Gene-Edited Seeds Market for Base Editing, By Country/Region, 2024-2036 (USD Million)
  • Table 7. Global Gene-Edited Seeds Market for Prime Editing, By Country/Region, 2024-2036 (USD Million)
  • Table 8. Global Gene-Edited Seeds Market for Oligonucleotide-Directed Mutagenesis, By Country/Region, 2024-2036 (USD Million)
  • Table 9. Global Gene-Edited Seeds Market for TALEN-Based Editing, By Country/Region, 2024-2036 (USD Million)
  • Table 10. Global Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 11. Global Gene-Edited Seeds Market for Herbicide Tolerance, By Country/Region, 2024-2036 (USD Million)
  • Table 12. Global Gene-Edited Seeds Market for Disease & Pest Resistance, By Country/Region, 2024-2036 (USD Million)
  • Table 13. Global Gene-Edited Seeds Market for Yield & Compositional/Quality Improvement, By Country/Region, 2024-2036 (USD Million)
  • Table 14. Global Gene-Edited Seeds Market for Abiotic Stress Tolerance, By Country/Region, 2024-2036 (USD Million)
  • Table 15. Global Gene-Edited Seeds Market for Other Traits, By Country/Region, 2024-2036 (USD Million)
  • Table 16. Global Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 17. Global Gene-Edited Seeds Market for Corn, By Country/Region, 2024-2036 (USD Million)
  • Table 18. Global Gene-Edited Seeds Market for Soybean, By Country/Region, 2024-2036 (USD Million)
  • Table 19. Global Gene-Edited Seeds Market for Wheat, By Country/Region, 2024-2036 (USD Million)
  • Table 20. Global Gene-Edited Seeds Market for Rice, By Country/Region, 2024-2036 (USD Million)
  • Table 21. Global Gene-Edited Seeds Market for Canola & Oilseed Rape, By Country/Region, 2024-2036 (USD Million)
  • Table 22. Global Gene-Edited Seeds Market for Cotton, By Country/Region, 2024-2036 (USD Million)
  • Table 23. Global Gene-Edited Seeds Market for Fruits, Vegetables & Specialty Crops, By Country/Region, 2024-2036 (USD Million)
  • Table 24. Global Gene-Edited Seeds Market for Other Crops, By Country/Region, 2024-2036 (USD Million)
  • Table 25. Global Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 26. Global Gene-Edited Seeds Market for SDN-1, By Country/Region, 2024-2036 (USD Million)
  • Table 27. Global Gene-Edited Seeds Market for SDN-2, By Country/Region, 2024-2036 (USD Million)
  • Table 28. Global Gene-Edited Seeds Market for SDN-3/Cisgenic, By Country/Region, 2024-2036 (USD Million)
  • Table 29. Global Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 30. Global Gene-Edited Seeds Market for Row Crop & Field Crop Growers, By Country/Region, 2024-2036 (USD Million)
  • Table 31. Global Gene-Edited Seeds Market for Specialty Crop Growers, By Country/Region, 2024-2036 (USD Million)
  • Table 32. Global Gene-Edited Seeds Market for Seed Companies (Trait Licensing), By Country/Region, 2024-2036 (USD Million)
  • Table 33. Global Gene-Edited Seeds Market for Food, Feed & Ingredient Processors, By Country/Region, 2024-2036 (USD Million)
  • Table 34. Global Gene-Edited Seeds Market, By Country/Region, 2024-2036 (USD Million)
  • Table 35. North America: Gene-Edited Seeds Market, By Country, 2024-2036 (USD Million)
  • Table 36. North America: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 37. North America: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 38. North America: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 39. North America: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 40. North America: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 41. U.S.: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 42. U.S.: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 43. U.S.: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 44. U.S.: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 45. U.S.: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 46. Canada: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 47. Canada: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 48. Canada: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 49. Canada: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 50. Canada: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 51. Europe: Gene-Edited Seeds Market, By Country, 2024-2036 (USD Million)
  • Table 52. Europe: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 53. Europe: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 54. Europe: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 55. Europe: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 56. Europe: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 57. Germany: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 58. Germany: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 59. Germany: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 60. Germany: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 61. Germany: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 62. U.K.: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 63. U.K.: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 64. U.K.: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 65. U.K.: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 66. U.K.: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 67. France: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 68. France: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 69. France: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 70. France: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 71. France: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 72. Spain: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 73. Spain: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 74. Spain: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 75. Spain: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 76. Spain: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 77. Italy: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 78. Italy: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 79. Italy: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 80. Italy: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 81. Italy: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 82. Netherlands: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 83. Netherlands: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 84. Netherlands: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 85. Netherlands: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 86. Netherlands: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 87. Nordic Countries: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 88. Nordic Countries: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 89. Nordic Countries: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 90. Nordic Countries: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 91. Nordic Countries: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 92. Rest of Europe: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 93. Rest of Europe: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 94. Rest of Europe: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 95. Rest of Europe: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 96. Rest of Europe: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 97. Asia-Pacific: Gene-Edited Seeds Market, By Country, 2024-2036 (USD Million)
  • Table 98. Asia-Pacific: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 99. Asia-Pacific: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 100. Asia-Pacific: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 101. Asia-Pacific: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 102. Asia-Pacific: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 103. China: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 104. China: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 105. China: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 106. China: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 107. China: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 108. India: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 109. India: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 110. India: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 111. India: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 112. India: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 113. Japan: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 114. Japan: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 115. Japan: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 116. Japan: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 117. Japan: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 118. South Korea: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 119. South Korea: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 120. South Korea: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 121. South Korea: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 122. South Korea: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 123. Australia & New Zealand: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 124. Australia & New Zealand: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 125. Australia & New Zealand: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 126. Australia & New Zealand: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 127. Australia & New Zealand: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 128. Rest of Asia-Pacific: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 129. Rest of Asia-Pacific: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 130. Rest of Asia-Pacific: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 131. Rest of Asia-Pacific: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 132. Rest of Asia-Pacific: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 133. Latin America: Gene-Edited Seeds Market, By Country, 2024-2036 (USD Million)
  • Table 134. Latin America: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 135. Latin America: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 136. Latin America: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 137. Latin America: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 138. Latin America: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 139. Brazil: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 140. Brazil: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 141. Brazil: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 142. Brazil: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 143. Brazil: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 144. Argentina: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 145. Argentina: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 146. Argentina: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 147. Argentina: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 148. Argentina: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 149. Mexico: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 150. Mexico: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 151. Mexico: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 152. Mexico: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 153. Mexico: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 154. Rest of Latin America: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 155. Rest of Latin America: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 156. Rest of Latin America: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 157. Rest of Latin America: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 158. Rest of Latin America: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 159. Middle East & Africa: Gene-Edited Seeds Market, By Country, 2024-2036 (USD Million)
  • Table 160. Middle East & Africa: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 161. Middle East & Africa: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 162. Middle East & Africa: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 163. Middle East & Africa: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 164. Middle East & Africa: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 165. Saudi Arabia: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 166. Saudi Arabia: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 167. Saudi Arabia: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 168. Saudi Arabia: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 169. Saudi Arabia: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 170. UAE: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 171. UAE: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 172. UAE: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 173. UAE: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 174. UAE: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 175. South Africa: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 176. South Africa: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 177. South Africa: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 178. South Africa: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 179. South Africa: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 180. Rest of Middle East & Africa: Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Table 181. Rest of Middle East & Africa: Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Table 182. Rest of Middle East & Africa: Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Table 183. Rest of Middle East & Africa: Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Table 184. Rest of Middle East & Africa: Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Table 185. Corteva, Inc.: Product Portfolio
  • Table 186. Bayer AG: Product Portfolio
  • Table 187. Basf SE: Product Portfolio
  • Table 188. Syngenta Group: Product Portfolio
  • Table 189. Kws Saat SE & Co. KGaA: Product Portfolio
  • Table 190. Groupe Limagrain: Product Portfolio
  • Table 191. J.R. Simplot Company: Product Portfolio
  • Table 192. Cibus, Inc.: Product Portfolio
  • Table 193. Pairwise: Product Portfolio
  • Table 194. Inari Agriculture, Inc.: Product Portfolio
  • Table 195. Tropic Biosciences Uk Limited: Product Portfolio
  • Table 196. Keygene N.V.: Product Portfolio
  • Table 197. Evogene Ltd.: Product Portfolio
  • Table 198. Beijing Dabeinong Technology Group Co., Ltd.: Product Portfolio
  • Table 199. Qi Biodesign: Product Portfolio
  • Table 200. Origin Agritech Limited: Product Portfolio

LIST OF FIGURES

List of Figures

  • Figure 1. Gene-Edited Seeds Market, Segmentation and Scope
  • Figure 2. Research Process
  • Figure 3. Secondary Sources Referenced for This Study
  • Figure 4. Primary Research Techniques
  • Figure 5. Key Executives Interviewed
  • Figure 6. Breakdown of Primary Interviews (Supply-Side and Demand-Side, By Region)
  • Figure 7. Market Sizing and Growth Forecast Approach
  • Figure 8. Global Gene-Edited Seeds Market, By Editing Technology, 2026 Vs. 2036 (USD Million)
  • Figure 9. Global Gene-Edited Seeds Market, By Trait, 2026 Vs. 2036 (USD Million)
  • Figure 10. Global Gene-Edited Seeds Market, By Crop Type, 2026 Vs. 2036 (USD Million)
  • Figure 11. Global Gene-Edited Seeds Market, By Regulatory Category, 2026 Vs. 2036 (USD Million)
  • Figure 12. Global Gene-Edited Seeds Market, By End User, 2026 Vs. 2036 (USD Million)
  • Figure 13. Global Gene-Edited Seeds Market, By Geography
  • Figure 14. Gene-Edited Seeds Market: Competitive Dashboard
  • Figure 15. Commercial Gene-Edited Crop Products and Regulatory Milestones, 2019-2026
  • Figure 16. Gene-Edited Seeds Market, Market Ecosystem
  • Figure 17. Gene-Edited Seeds Market, Factors Affecting Market Growth
  • Figure 18. Regulatory Pathways for Gene-Edited Plants in Major Markets
  • Figure 19. Trait Development Timelines: Conventional, Transgenic and Gene-Edited
  • Figure 20. Climate-Resilience and Input-Efficiency Traits in Gene-Edited Crop Pipelines
  • Figure 21. U.S. Regulatory Transition Following the December 2024 Vacatur
  • Figure 22. Specialty Crop Gene-Editing Partnerships and Licensing
  • Figure 23. Gene-Edited Crop Approvals and Releases in India and China
  • Figure 24. Corteva V. Inari: Litigation Timeline
  • Figure 25. Corporate Realignment Around Gene Editing, 2023-2026
  • Figure 26. Evolution from Single-Gene Knockouts to Multiplexed and Fine-Tuned Editing
  • Figure 27. Key Vendor Selection Criteria
  • Figure 28. Use Cases for Gene-Edited Seeds
  • Figure 29. Porter's Five Forces Analysis
  • Figure 30. Gene-Edited Seeds Market, Value Chain Analysis
  • Figure 31. Revenue Models: Trait Licensing Royalty Versus Seed Premium
  • Figure 32. Editing Platforms and Intellectual Property Layers
  • Figure 33. Gene-Edited Trait Pipeline by Crop, Trait and Stage
  • Figure 34. Regulatory Frameworks for Gene-Edited Plants, By Country
  • Figure 35. EU NGT Regulation: NGT-1 and NGT-2 Categories
  • Figure 36. Public and Public-Private Gene-Editing Programmes, By Region
  • Figure 37. PESTEL Analysis of the Gene-Edited Seeds Market
  • Figure 38. Comparison of Genome-Editing Technologies Used in Seed Development
  • Figure 39. Global Gene-Edited Seeds Market, By Editing Technology, 2026 Vs. 2036 (USD Million)
  • Figure 40. Global Gene-Edited Seeds Market, By Editing Technology, 2024-2036 (USD Million)
  • Figure 41. Global Gene-Edited Seeds Market for CRISPR-Cas9-Based Editing, By Country/Region, 2024-2036 (USD Million)
  • Figure 42. Global Gene-Edited Seeds Market for CRISPR-Cas12a (Cpf1)-Based Editing, By Country/Region, 2024-2036 (USD Million)
  • Figure 43. Global Gene-Edited Seeds Market for Base Editing, By Country/Region, 2024-2036 (USD Million)
  • Figure 44. Global Gene-Edited Seeds Market for Prime Editing, By Country/Region, 2024-2036 (USD Million)
  • Figure 45. Global Gene-Edited Seeds Market for Oligonucleotide-Directed Mutagenesis, By Country/Region, 2024-2036 (USD Million)
  • Figure 46. Global Gene-Edited Seeds Market for TALEN-Based Editing, By Country/Region, 2024-2036 (USD Million)
  • Figure 47. Gene-Edited Traits by Category, Example Products and Regulatory Status
  • Figure 48. Global Gene-Edited Seeds Market, By Trait, 2026 Vs. 2036 (USD Million)
  • Figure 49. Global Gene-Edited Seeds Market, By Trait, 2024-2036 (USD Million)
  • Figure 50. Global Gene-Edited Seeds Market for Herbicide Tolerance, By Country/Region, 2024-2036 (USD Million)
  • Figure 51. Global Gene-Edited Seeds Market for Disease & Pest Resistance, By Country/Region, 2024-2036 (USD Million)
  • Figure 52. Global Gene-Edited Seeds Market for Yield & Compositional/Quality Improvement, By Country/Region, 2024-2036 (USD Million)
  • Figure 53. Global Gene-Edited Seeds Market for Abiotic Stress Tolerance, By Country/Region, 2024-2036 (USD Million)
  • Figure 54. Global Gene-Edited Seeds Market for Other Traits, By Country/Region, 2024-2036 (USD Million)
  • Figure 55. Gene-Edited Products and Pipelines, By Crop
  • Figure 56. Global Gene-Edited Seeds Market, By Crop Type, 2026 Vs. 2036 (USD Million)
  • Figure 57. Global Gene-Edited Seeds Market, By Crop Type, 2024-2036 (USD Million)
  • Figure 58. Global Gene-Edited Seeds Market for Corn, By Country/Region, 2024-2036 (USD Million)
  • Figure 59. Global Gene-Edited Seeds Market for Soybean, By Country/Region, 2024-2036 (USD Million)
  • Figure 60. Global Gene-Edited Seeds Market for Wheat, By Country/Region, 2024-2036 (USD Million)
  • Figure 61. Global Gene-Edited Seeds Market for Rice, By Country/Region, 2024-2036 (USD Million)
  • Figure 62. Global Gene-Edited Seeds Market for Canola & Oilseed Rape, By Country/Region, 2024-2036 (USD Million)
  • Figure 63. Global Gene-Edited Seeds Market for Cotton, By Country/Region, 2024-2036 (USD Million)
  • Figure 64. Global Gene-Edited Seeds Market for Fruits, Vegetables & Specialty Crops, By Country/Region, 2024-2036 (USD Million)
  • Figure 65. Global Gene-Edited Seeds Market for Other Crops, By Country/Region, 2024-2036 (USD Million)
  • Figure 66. Site-Directed Nuclease Categories and Their Regulatory Treatment, By Country
  • Figure 67. Global Gene-Edited Seeds Market, By Regulatory Category, 2026 Vs. 2036 (USD Million)
  • Figure 68. Global Gene-Edited Seeds Market, By Regulatory Category, 2024-2036 (USD Million)
  • Figure 69. Global Gene-Edited Seeds Market for SDN-1, By Country/Region, 2024-2036 (USD Million)
  • Figure 70. Global Gene-Edited Seeds Market for SDN-2, By Country/Region, 2024-2036 (USD Million)
  • Figure 71. Global Gene-Edited Seeds Market for SDN-3/Cisgenic, By Country/Region, 2024-2036 (USD Million)
  • Figure 72. Gene-Edited Seed End Users and Their Purchase Drivers
  • Figure 73. Global Gene-Edited Seeds Market, By End User, 2026 Vs. 2036 (USD Million)
  • Figure 74. Global Gene-Edited Seeds Market, By End User, 2024-2036 (USD Million)
  • Figure 75. Global Gene-Edited Seeds Market for Row Crop & Field Crop Growers, By Country/Region, 2024-2036 (USD Million)
  • Figure 76. Global Gene-Edited Seeds Market for Specialty Crop Growers, By Country/Region, 2024-2036 (USD Million)
  • Figure 77. Global Gene-Edited Seeds Market for Seed Companies (Trait Licensing), By Country/Region, 2024-2036 (USD Million)
  • Figure 78. Global Gene-Edited Seeds Market for Food, Feed & Ingredient Processors, By Country/Region, 2024-2036 (USD Million)
  • Figure 79. Global Gene-Edited Seeds Market, By Geography, 2026 Vs. 2036 (USD Million)
  • Figure 80. Global Gene-Edited Seeds Market, By Geography, 2024-2036 (USD Million)
  • Figure 81. Global Gene-Edited Seeds Market: Geographic Snapshot
  • Figure 82. North America: Gene-Edited Seeds Market Snapshot
  • Figure 83. North America: Gene-Edited Seeds Market, By Country, 2024-2036 (USD Million)
  • Figure 84. North America: Gene-Edited Products and Regulatory Determinations
  • Figure 85. U.S.: Regulatory Transition Following the December 2024 Vacatur of the SECURE Rule
  • Figure 86. Canada: Regulatory Guidance for Gene-Edited Plants and Foods
  • Figure 87. Europe: Gene-Edited Seeds Market Snapshot
  • Figure 88. Europe: Gene-Edited Seeds Market, By Country, 2024-2036 (USD Million)
  • Figure 89. Europe: Timeline of the New Genomic Techniques Regulation
  • Figure 90. U.K.: Precision Breeding Authorisation Pathway in England
  • Figure 91. Italy: Field Trials of Gene-Edited Crops Under the 2023 Assisted Evolution Techniques Law
  • Figure 92. Asia-Pacific: Gene-Edited Seeds Market Snapshot
  • Figure 93. Asia-Pacific: Gene-Edited Seeds Market, By Country, 2024-2036 (USD Million)
  • Figure 94. Asia-Pacific: Regulatory Status of Gene-Edited Plants, By Country
  • Figure 95. China: Gene-Edited Crop Approvals, 2023-2024
  • Figure 96. India: Genome-Edited Rice Varieties Released in May 2025
  • Figure 97. Australia & New Zealand: Regulatory Reforms for Gene-Edited Plants and Foods
  • Figure 98. Rest of Asia-Pacific: Genome-Editing Frameworks Adopted Since 2022
  • Figure 99. Latin America: Gene-Edited Seeds Market Snapshot
  • Figure 100. Latin America: Gene-Edited Seeds Market, By Country, 2024-2036 (USD Million)
  • Figure 101. Latin America: Regulatory Procedures for Gene-Edited Plants, By Country
  • Figure 102. Brazil: CTNBio Consultation Procedure Under Normative Resolution No. 16
  • Figure 103. Rest of Latin America: Gene-Edited Product Approvals and Procedures
  • Figure 104. Middle East & Africa: Gene-Edited Seeds Market Snapshot
  • Figure 105. Middle East & Africa: Gene-Edited Seeds Market, By Country, 2024-2036 (USD Million)
  • Figure 106. Middle East & Africa: Regulatory Approaches to Gene-Edited Plants, By Country
  • Figure 107. South Africa: Regulatory Decisions on New Breeding Techniques, 2021-2024
  • Figure 108. Gene-Edited Seeds Market: Competitive Structure
  • Figure 109. Key Growth Strategies Adopted by Leading Market Players, 2025-2026
  • Figure 110. Strategic Developments, By Company, 2025-2026
  • Figure 111. Gene-Edited Seeds Market: Competitive Benchmarking, By Crop Coverage
  • Figure 112. Gene-Edited Seeds Market: Competitive Benchmarking, By Editing Platform
  • Figure 113. Gene-Edited Seeds Market: Competitive Benchmarking, By Trait Pipeline
  • Figure 114. Gene-Edited Seeds Market: Competitive Benchmarking, By Registered Geographies
  • Figure 115. Competitive Dashboard: Gene-Edited Seeds Market
  • Figure 116. Global Gene-Edited Seeds Market Share Analysis, By Key Players (2025)
  • Figure 117. Top Four Players: Gene-Editing Position and Basis of Share, 2025
  • Figure 118. Corteva, Inc.: Company Snapshot
  • Figure 119. Corteva, Inc.: SWOT Analysis
  • Figure 120. Bayer AG: Company Snapshot
  • Figure 121. Bayer AG: SWOT Analysis
  • Figure 122. Basf SE: Company Snapshot
  • Figure 123. Basf SE: SWOT Analysis
  • Figure 124. Syngenta Group: Company Snapshot
  • Figure 125. Syngenta Group: SWOT Analysis
  • Figure 126. Kws Saat SE & Co. KGaA: Company Snapshot
  • Figure 127. Kws Saat SE & Co. KGaA: SWOT Analysis
  • Figure 128. Groupe Limagrain: Company Snapshot
  • Figure 129. Groupe Limagrain: SWOT Analysis
  • Figure 130. J.R. Simplot Company: Company Snapshot
  • Figure 131. J.R. Simplot Company: SWOT Analysis
  • Figure 132. Cibus, Inc.: Company Snapshot
  • Figure 133. Cibus, Inc.: SWOT Analysis
  • Figure 134. Pairwise: Company Snapshot
  • Figure 135. Pairwise: SWOT Analysis
  • Figure 136. Inari Agriculture, Inc.: Company Snapshot
  • Figure 137. Inari Agriculture, Inc.: SWOT Analysis
  • Figure 138. Tropic Biosciences Uk Limited: Company Snapshot
  • Figure 139. Tropic Biosciences Uk Limited: SWOT Analysis
  • Figure 140. Keygene N.V.: Company Snapshot
  • Figure 141. Keygene N.V.: SWOT Analysis
  • Figure 142. Evogene Ltd.: Company Snapshot
  • Figure 143. Evogene Ltd.: SWOT Analysis
  • Figure 144. Beijing Dabeinong Technology Group Co., Ltd.: Company Snapshot
  • Figure 145. Beijing Dabeinong Technology Group Co., Ltd.: SWOT Analysis
  • Figure 146. Qi Biodesign: Company Snapshot
  • Figure 147. Qi Biodesign: SWOT Analysis
  • Figure 148. Origin Agritech Limited: Company Snapshot
  • Figure 149. Origin Agritech Limited: SWOT Analysis